期刊文献+

Toll样受体在慢性阻塞性肺疾病发病机制中的作用 被引量:3

Mechanisms of role of Toll-like receptors in the pathogenesis of chronic obstructive pulmonary disease
原文传递
导出
摘要 慢性阻塞性肺疾病(COPD)是一种以气道炎症为主要标志的慢性呼吸系统疾病。而COPD气道炎症的启动、激发和炎性信号级联放大机制尚不甚明了。近年来研究表明模式识别受体(PRRs)在COPD慢性炎症的启动和维持过程中扮演着重要角色。其中,尤以Toll样受体(TLRs)与COPD发病关系最为密切。吸烟、有害气体、微生物及损伤相关分子模式(DAMPs)与TLRs相互作用,通过NF-κB信号转导通路完成跨膜信号转导,最终调节炎症基因的转录和翻译,产生大量炎症介质并趋化大量炎症细胞参与气道炎症反应的启动及维持。本文结合近年来国内外的最新相关研究成果,对TLRs及下游信号转导通路在COPD发病机制中的重要作用综述如下。 Chronic obstructive pulmonary disease(COPD) is one of chronic respiratory disease characterized by airway inflammation. However, the mechanism of the initiation and trigger and cascade of inflammation responses is still not clear. In recent years, pattern recognition receptors(PRRs), especially Toll-like receptors(TLRs) are thought as key players in the initiation and sustaining of inflammatory responses in patients with COPD. TLRs interact with cigarette smoke(CS), noxious gases, pathogen- associated molecular patterns(PAMPs) and damage associate molecular patterns(DAMPs) that are released in response to cell injury. Transmembrane signal transduction through NF-κB pathway leads to persistent airway inflammation via transcription and translation of inflammatory genes, formation and release of pro-inflammatory cytokines and chemokines as well as neutrophils with other inflammatory active cells recruited. Combining the domestic and foreign research results, this review will explore TLR and molecular signaling pathway and their potential roles in COPD.
出处 《中华临床医师杂志(电子版)》 CAS 2014年第4期110-112,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 肺疾病 慢性阻塞性 TOLL样受体 信号传导 气道炎症 Pulmonary disease chronic obstructive Toll-like receptors Signal transduction Airway inflammation
  • 相关文献

参考文献21

  • 1Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease(revised 2011)[EB/OL].http://www.goldCOPD.org/guidelines-pocket-guide-to-COPD-diagnosis.html.
  • 2Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey[J].Am J Respir Crit Care Med,2007,176(8):753-760.
  • 3Hansel TT,Barnes PJ.New drugs for exacerbations of chronic obstructive pulmonary disease[J].Lancet,2009,374(9691):744-755.
  • 4Opitz B,van Laak V,Eitel J,et al.Innate immune recognition in infectious and noninfectious diseases of the lung[J].Am J Respir Crit Care Med,2010,181(12):1294-1309.
  • 5田志刚.固有免疫[M]//何维.医学免疫学.北京:人民卫生出版社,2006:143-147.
  • 6Kumar H,Kawai T,Akira S.Pathogen recognition in the innate immune response[J].Biochem J,2009,420:1-16.
  • 7Rohmann K,Tschernig T,Pabst R,et al.Innate immunity in the human lung:pathogen recognition and lung disease[J].Cell Tissue Res,2011,343(1):167-174.
  • 8Hoebe K,Du X,Georgel P,et al.Identification of Lps2 as a key transducer of MyD88-independent TIR signalling[J].Nature,2003,424(6950):743-748.
  • 9Song KW,Talamas FX,Suttmann RT,et al.The kinase activities of interleukin-1 receptor associated kinase(IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells[J].Mol Immunol,2009,46(7):1458-1466.
  • 10Yang S R,Chida AS,Bauter MR,et al.Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages[J].Am J Physiol Lung Cell Mol Physiol,2006,291(1):46-57.

同被引文献26

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部